Gene Therapy for Retinal and Neurological DiseasesByMagali Taiel, MDSeptember 3rd 2021Magali Taiel, MD, chief medical officer, GenSight Biologics, discussed future research the company plans to pursue.
Targeting LHON and Retinitis Pigmentosa With Gene Therapy ByMagali Taiel, MDAugust 13th 2021Magali Taiel, MD, chief medical officer, GenSight Biologics, discussed the company’s work in ophthalmic diseases.